https://www.selleckchem.com/pr....oducts/brincidofovir
SR 59230A and butoxamine significantly increased contractions in the ovarian cancer group (both p 0.001). These results require now to be placed into a firm clinical context. Our study indicates that ovarian cancer considerably alters contractile activity of the nonpregnant human uterus in response to ADRB antagonists. This suggests a pathogenetic role of beta-adrenergic pathways in this malignancy. Furthermore, propranolol and bupranolol substantially influence spontaneous uterine contractility. Our study indicates that ovar
Like
Comment
Share
